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Abstract
Background: The Saccharomyces cerevisiae MYO1 gene encodes the myosin II heavy chain (Myo1p), a protein required
for normal cytokinesis in budding yeast. Myo1p deficiency in yeast (myo1∆) causes a cell separation defect characterized
by the formation of attached cells, yet it also causes abnormal budding patterns, formation of enlarged and elongated
cells, increased osmotic sensitivity, delocalized chitin deposition, increased chitin synthesis, and hypersensitivity to the
chitin synthase III inhibitor Nikkomycin Z. To determine how differential expression of genes is related to these diverse
cell wall phenotypes, we analyzed the global mRNA expression profile of myo1∆ strains.
Results: Global mRNA expression profiles of myo1∆ strains and their corresponding wild type controls were obtained
by hybridization to yeast oligonucleotide microarrays. Results for selected genes were confirmed by real time RT-PCR.
A total of 547 differentially expressed genes (p ≤ 0.01) were identified with 263 up regulated and 284 down regulated
genes in the myo1∆ strains. Gene set enrichment analysis revealed the significant over-representation of genes in the
protein biosynthesis and stress response categories. The SLT2/MPK1 gene was up regulated in the microarray, and a
myo1∆slt2∆ double mutant was non-viable. Overexpression of ribosomal protein genes RPL30 and RPS31 suppressed the
hypersensitivity to Nikkomycin Z and increased the levels of phosphorylated Slt2p in myo1∆ strains. Increased levels of
phosphorylated Slt2p were also observed in wild type strains under these conditions.
Conclusion: Following this analysis of global mRNA expression in yeast myo1∆ strains, we conclude that 547 genes were
differentially regulated in myo1∆ strains and that the stress response and protein biosynthesis gene categories were
coordinately regulated in this mutant. The SLT2/MPK1 gene was confirmed to be essential for myo1∆ strain viability,
supporting that the up regulated stress response genes are regulated by the PKC1 cell integrity pathway. Suppression of
Nikkomycin Z hypersensitivity together with Slt2p phosphorylation was caused by the overexpression of ribosomal
protein genes RPL30 and RPS31. These ribosomal protein mRNAs were down regulated in the myo1∆ arrays, suggesting
that down regulation of ribosomal biogenesis may affect cell integrity in myo1∆ strains.
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Background
In yeast cells as in animal cells, cytokinesis requires the
formation of an actomyosin contractile ring [1]. Saccharo-
myces cerevisiae possesses a single MYO1  gene, which
encodes the myosin II heavy chain protein (Myo1p), the
only conventional myosin II of the budding yeast. Myo1p
is associated with F-actin during formation of the contrac-
tile apparatus, and provides the actin-activated ATPase
activity driving the contraction of the actomyosin ring at
cytokinesis [2,3]. Previous studies have described the
importance of Myo1p in cytokinesis in yeast by establish-
ing that myosin II concentrates at the bud neck, contracts
during the cytokinesis, and subsequently is redistributed
or degraded after the completion of mitosis [2,4].
In addition to the loss of normal cytokinesis function,
myo1∆ strains present phenotypes such as the formation
of attached cells, loss of axial budding pattern, cell
enlargement, osmotic hypersensitivity, delocalized chitin
deposition [5], increased chitin synthesis[6,7], and hyper-
sensitivity to Nikkomycin Z [8]. The diversity of these phe-
notypes, many of which can be associated with cell wall
organization, suggests that myosin II may affect cellular
functions other than cytokinesis. The purpose of this
study was to generate a global mRNA expression profile of
myo1∆ strains using yeast oligonucleotide microarrays to
identify potential relationships between the multiple
myo1∆ phenotypes mentioned and changes in the tran-
scription profile of specific genes that can be functionally
related to these phenotypes.
Results and Discussion
The results of independent microarray hybridization
experiments conducted with two different myo1∆ knock-
out strains were averaged and combined for comparison
with the corresponding wild-type control values. Our
rationale for this experimental design was to identify def-
erentially regulated genes held in common between at
least two different myo1∆ strain backgrounds in order to
eliminate any strain specific differences and preserve
strictly myo1∆-dependent genetic phenotypes. Cells were
cultured in Histidine dropout medium or CSM to main-
tain the culture conditions under which myo1∆  strains
have been shown to require chitin synthase III expression
for their survival [8] as well as to maintain equivalent
growth conditions between mutant and wild-type strains,
respectively.
Up regulated genes in myo1∆
Previously published studies reported differentially
expressed genes under conditions such as cell wall muta-
tions, chemical and biochemical perturbations of the cell
wall [9], diverse mutations covering 4% of the yeast
genome [10], and during the cell cycle [11], employing
values with p ≤ 0.05. We identified 97 genes in common
with these previous studies out of a total of 2,273 genes
with p ≤ 0.05 that were differentially expressed in myo1∆
strains (data not shown).
To refine this analysis we used a more stringent cutoff (p
≤ 0.01) to identify 547 differentially expressed genes in
myo1∆ strains. We observed a total of 263 up regulated
genes in myo1∆ strains compared to the wild type control
strains. The functional categories of the up regulated genes
that were represented as listed in the Saccharomyces
Genome Database (SGD) were: cell organization and bio-
genesis (17/263), metabolism (25/263), transport (9/
263), carbohydrate metabolism (23/263), stress response
(17/263), protein biosynthesis (2/263), cell cycle (3/
263), signal transduction (7/263), transcription (1/263),
sporulation (4/263), budding (4/263), RNA processing
(4/263), protein transport (6/263), protein amino acid
phosphorylation (2/263), protein amino acid dephos-
phorylation (1/263), autophagy (2/263), DNA repair (5/
263), cell growth and maintenance (1/263), and
unknown functions (130/263) (Additional file 1).
The results of this DNA microarrays analysis were vali-
dated by real time RT-PCR using a subset of these up reg-
ulated genes. The real time RT-PCR results indicated a fold
change of 1.8, 3.5, 13.0, 3.8, 3.5 and 2.3 for SLT2, ECM4,
SPI1, YHR097C, ROM1 and IRA2 respectively that were
consistent with the microarray results (Table 1).
Down regulated genes in myo1∆
A total of 284 genes were down regulated in the myo1∆
strains. As was expected for the knockout mutation, the
MYO1  gene was identified among the down regulated
genes in myo1∆ strains (4.5-fold, Additional file 1). Repre-
sented functional categories established by the SGD were:
cell organization and biogenesis (59/284), transport (16/
284), protein biosynthesis (72/284), metabolism (39/
Table 1: Validation of DNA microarray results. mRNAs were 
selected for real time RT-PCR analysis from the list of 
differentially expressed genes in myo1∆ with p < 0.01(Additional 
File 1). Fold-change was estimated by a semi-quantitative 
method as described in the Methods section.
Gene name Fold Change in 
Microarray
Fold Change 
(real time RT-PCR)
Up regulated genes
SLT2 2.1 1.8
ECM4 3.2 3.5
SPI1 8.6 13.0
YHR097C 4.1 3.8
ROM1 3.2 3.5
IRA2 3.7 2.3
Down regulated genes
RPL30 3.1 6.3
RPS31 2.6 7.7BMC Genomics 2008, 9:34 http://www.biomedcentral.com/1471-2164/9/34
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284), DNA metabolism (12/284), carbohydrate metabo-
lism (7/284), stress response (2/284), cell cycle (5/284),
signal transduction (1/284), transcription (5/284), sporu-
lation (2/284), budding (5/284), cell growth and mainte-
nance (1/284), protein transport (4/284), DNA damage
response (1/284), RNA localization (1/284), protein
amino acid phosphorylation (1/284), RNA processing (5/
284), and genes of unknown function (46/284) (Addi-
tional File 1). Real time RT-PCR results for RPL30 and
RPS31  indicated negative fold changes of 6.3 and 7.7
respectively that were consistent with the microarray
results (Table 1).
Gene Set Enrichment Analysis
In order to identify functionally related gene sets that were
differentially expressed and behaved in a coordinated
fashion in the myo1∆ strains, a Gene Set Enrichment Anal-
ysis (GSEA) [12] was performed. This kind of analysis is
useful for whole genome expression assays, because it
allows the visualization of the data in groups and how
these groups are represented in the microarray. For this
analysis a gene set was created for all the 6,256 genes con-
tained in the array, considering the t-value for each gene,
and then calculating the mean of the t-values for each cat-
egory. The genes were classified in categories by biological
function according to the Saccharomyces genome database
(SGD) [13]. The GSEA analysis was performed using the
Limma package from Bioconductor [14] as described in
the materials and methods section. Of the 25 categories
considered for GSEA, there were five categories with a cor-
rected p-value below the cutoff (p-value ≤ 0.0004). These
categories were: protein biosynthesis, stress response,
RNA processing, carbohydrate metabolism and genes of
unknown function. Histograms of density versus t-value
were generated for each category to observe the distribu-
tion of genes of a specific category compared with the nor-
mal distribution of all the categories on the arrays (Figure
1A.). Plots of t-values vs. A-values were created to identify
the genes in each category and observe their distribution
across the array (Figure 1B). Of the five gene categories
selected, the protein biosynthesis and stress response cat-
egories presented the most dramatic changes in their nor-
mal distribution. Although the other three categories had
p-values below the cutoff, when we observe their respec-
tive histograms there were less dramatic differences in the
distribution of each group compared to the whole micro-
array. The protein biosynthesis category is interesting
because the histogram shows a shift from the normal dis-
tribution towards negative t-values (Figure 1A). This is
also observed in the corresponding t-value vs. A-value plot
where we can see a greater quantity of genes biased
towards negative t-values (Figure 1B). This result was pre-
dictable due to the great quantity of genes related to pro-
tein biosynthesis that were down regulated in the
microarray. Within the protein biosynthesis gene category
there were an unusually high number of ribosomal pro-
tein genes that were down regulated suggesting that ribos-
ome biogenesis may be affected in the myo1∆ strains. This
interpretation would be consistent with the relatively slow
growth rate reported for these cells compared to their
wild-type controls [5]. Conversely, in the histogram for
stress response genes, there was a shift from the normal
distribution of the array towards positive t-values (Figure
1A). This shift can be explained by the up-regulation of
stress response genes with high t-values, therefore causing
this type of shift to the right of the normal distribution
curve. Considering the t-value vs. A-value plot, the stress
response genes were distributed above zero towards posi-
tives t-values. Among these stress response genes were
GRE1 and GRE3 that are regulated by the High Osmolarity
Glycerol response-signaling pathway (HOG) [15].
Another stress response gene that had the highest t-value
was HOR7. This gene encodes a putative GPI anchored
cell wall protein of unknown function that was also previ-
ously reported to be related to high osmolarity response
[15]. Differential expression of these genes indicates that
genes in this pathway may become activated in myo1∆
strains despite the absence of hyperosmotic conditions in
our experimental design. However, a hog1∆ deletion was
viable in these myo1∆ strains indicating that this pathway
is not essential for myo1∆ cell viability under our culture
conditions (data not shown).
Although the "unknown function" category had a greater
representation of differentially expressed genes in the
array, there was no shift in the density vs. t-values histo-
gram (Figure 1A) or the t-values vs. A-values plot (Figure
1B). Due to the fact that this category also has more genes
represented in the yeast genome, this group was not con-
sidered of interest for this analysis. However, we are aware
that this category represents the majority population of
differentially expressed genes many of which exhibit
extraordinary fold-changes in the double-digit range.
These could represent a pool of genes with potentially
novel functions related to cell proliferation, cell division,
and cell wall organization.
Carbohydrate metabolism was another functional cate-
gory exhibiting a large number of genes with dramatic
ranges in mRNA expression levels. The GSEA results for
this category showed a bimodal distribution (Figure 1A).
However, in the t-value vs. A-value plot these genes were
distributed throughout the array with no apparent bias
towards negative or positive t-values (Figure 1B). This
bimodal distribution may be significant as it may repre-
sent the existence of two sub-populations of genes with
distinct behaviors.BMC Genomics 2008, 9:34 http://www.biomedcentral.com/1471-2164/9/34
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Histograms derived from Gene Set Enrichment Analysis for categories with a corrected p-value ≤ 00004 Figure 1
Histograms derived from Gene Set Enrichment Analysis for categories with a corrected p-value ≤ 0.0004. A) Density versus t-
value plots for protein biogenesis, stress response, unknown, carbohydrate metabolism, and RNA processing categories. Red 
lines represent the distribution of genes of a specific category in the array. Black lines represent the distribution of all genes in 
the array. B) t-value versus A-value plots for protein biogenesis, stress response, unknown, carbohydrate metabolism, and 
RNA processing categories. Red dots represent the genes of a specific category in the array. Black dots represent the distribu-
tion of all genes in the array. The cutoff for a significant category is based on a p-value calculated after 10,000 permutations and 
then a corrected p-value was calculated using the Bonferroni correction. See Methods section for details.BMC Genomics 2008, 9:34 http://www.biomedcentral.com/1471-2164/9/34
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Differential regulation of Pkc1p/Slt2p cell integrity 
pathway
The SLT2/MPK1gene that encodes a serine/threonine MAP
kinase involved in regulating the maintenance of cell
integrity [9,16-18] was up regulated approximately 2-fold
in the myo1∆ strains (Table 1 and Additional file 1). In
other studies it was reported that phospho-Slt2p was also
activated in the myo1∆ mutant compared to the wild type
strain [19,20]. A previous study defined a cluster of 20
genes regulated by this PKC1-mediated signaling pathway
that were strongly induced by chemical perturbation of
the cell wall with Congo red dye, by enzymatic treatment
with Zymolyase, or by mutations in specific cell wall
genes such as KRE6, GAS1, FKS1, MNN9 and KNR4 [9].
SED1, HSP12, SLT2, FBP26 and YHR097C (Additional file
1) represent five of these 20 genes that were also up regu-
lated in the myo1∆ strains (p ≤ 0.01) further supporting
that the PKC1  signaling pathway is activated. A
myo1∆slt2∆ strain expressing the MYO1 gene on a pRS316
plasmid was grown at 26°C in 5-FOA to extract the plas-
mid and generate the myo1∆slt2∆ double knockout. After
three days, no growth was observed for the myo1∆slt2∆
double knockout (Figure 2A). This result corroborates
that slt2∆ is synthetically lethal in a myo1∆ mutant and
supports that the cell integrity pathway is essential for via-
bility in these strains [20].
Suppression of Nikkomycin Z hypersensitivity by 
overexpression of ribosomal protein genes
Gene Set Enrichment Analysis showed that protein bio-
synthesis genes were coordinately down regulated in these
myo1∆ strains (Figure 1B). RPL30 and RPS31 ribosomal
protein genes were among those differentially expressed
in the myo1∆ microarrays. The RPL30 gene is essential in
budding yeast [21] and its protein product is a component
of the large ribosomal (60S) subunit. The RPS31  gene
product constitutes a fusion of a non-essential small
ribosomal (40S) subunit protein with ubiquitin, which
facilitates the assembly of ribosomal proteins into ribos-
omes and is required for the proper translation of GCN4,
a transcription factor that regulates amino acid biosynthe-
sis [22]. A previous screen for suppressors of Nikkomycin
Z (NZ) hypersensitivity in myo1∆  strains identified the
cDNAs encoding RPL30 and RPS31 among others [24].
Nikkomycin Z is a competitive inhibitor of Chs3p and our
previous studies established the hypersensitivity of myo1∆
strains to this antibiotic which inhibits cell growth and
affects cell integrity by blocking chitin synthesis [8].
Recombinant RPL30 and RPS31 conferred 67% and 69%
resistance to Nikkomycin Z respectively, when overex-
pressed by induction with 2% galactose (Figure 2B). We
confirmed increased transcription of both ribosomal pro-
tein cDNAs in a wild-type strain by real time RT-PCR (9.13
and 8.03 respectively). These results support that overex-
pression of ribosomal protein genes may suppresses NZ
hypersensitivity in myo1∆  strains by contributing to
restore cell integrity. Though the mechanism is unclear,
other RP genes identified in our previous study had a sim-
ilar effect.
Western blot analysis of the level of phosphorylated Slt2p 
in myo1∆ strains overexpressing RPL30 or RPS31
To relate suppression of NZ hypersensitivity with the res-
toration of cell integrity in myo1∆ strains, we assayed the
level of phosphorylated Slt2p (p-Slt2p) by Western blot. It
has been previously established that the cell integrity
pathway is activated in myo1∆  mutants [19,20]. Our
results show increases in p-Slt2p levels for myo1∆ strains
overexpressing RPL30 (myo1∆pRS316-RPL30) and RPS31
(myo1∆pRS316-RPS31) (Figure 2C). Moreover, we also
detected increases in p-Slt2p levels for wild type strains
overexpressing  RPL30  (wild type pRS316-RPL30) and
RPS31 (wild type pRS316-RPS31) genes in repressing and
inducing conditions (Figure 2C). The former observation
can be explained by leakage from the GAL1  promoter
under repressing conditions (data not shown) and sug-
gested that the activation of the cell integrity pathway can
respond to very minor changes in RP gene transcription.
When SLT2 mRNA levels were measured, the fold changes
for strains wild type pRS316-RPL30, wild type pRS316-
RPS31,  myo1∆pRS316-RPL30, and myo1∆pRS316-RPS31
were 1.21, 2.73, 1.6 and 6.5, respectively (see Table 2).
While both RP cDNAs had similar effects on p-Slt2p lev-
els, fold changes in SLT2  mRNA levels induced by RP
overexpression were consistently lower for RPL30 than for
RPS31.
Conclusion
Following our analysis of the global mRNA expression
profile in myo1∆  strains of Saccharomyces cerevisiae we
found that there were 547 differentially regulated genes.
Gene Set Enrichment Analysis indicated that stress
response and protein biosynthesis gene categories are
inversely related in this mutant. These results support that
cell wall morphogenetic processes were affected by
myosin II deficiency. The up-regulation of stress response
genes in the myo1∆ strains reflects the essentiality of the
cell integrity pathway and the importance of the PKC1-
mediated signaling pathway for survival in these strains.
The coordinated down-regulation of protein biosynthesis
genes can be related to a loss of cell wall integrity in this
mutant because overexpression of RPL30 and RPS31, two
differentially regulated ribosomal protein (RP) genes,
conferred Nikkomycin Z resistance to the hypersensitive
myo1∆ strains. Overexpression of RPL30 and RPS31 did
not shut down the cell integrity pathway supporting that
their overexpression promotes activation of the PKC1
pathway.BMC Genomics 2008, 9:34 http://www.biomedcentral.com/1471-2164/9/34
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The high frequency of ribosomal protein genes in the
down regulated gene category implies that ribosome bio-
genesis is greatly affected by myosin type II deficiency. It
has been proposed that yeast cells regulate ribosome bio-
genesis primarily by responding to growth limiting envi-
ronmental signals [23]. Cell wall and plasma membrane
stress may therefore represent such signals that can acti-
vate signaling pathways for regulating growth rate in the
absence of myosin II. We propose that this alteration in
the normal regulation of these processes may be necessary
for the completion of cytokinesis in the absence of a con-
tractile ring that must involve increased chitin synthesis
and extensive cell wall remodeling at the bud neck.
We previously demonstrated that overexpression of the
cDNA for ubiquitin conjugating enzyme UBC4 lowered
(A) Genetic disruption of the SLT2/MPK1 gene induces lethality in a myo1∆ strain Figure 2
(A) Genetic disruption of the SLT2/MPK1 gene induces lethality in a myo1∆ strain. Wild type, myo1∆, slt2∆ and myo1∆ 
slt2∆pRS316-MYO1 strains were grown in CSM (1 mg/ml) 5-FOA for three days at 26°C. (B)Suppression of Nikkomycin Z 
hypersensitivity in myo1∆ strains overexpressing the ribosomal protein genes RPL30 and RPS31. Wt, myo1∆, myo1∆pRS316-
RPL30 and myo1∆pRS316-RPS31 strains were grown CSM or CSM URA- in presence or absence of 6.25 µM Nikkomycin Z in 
2% glucose or 2% galactose for 48 hours at 26°C. Percent of Nikkomycin Z resistance was calculated as: (OD600 nm treated/
OD600nm untreated) × (100). Dark gray histograms represent cells where expression of the plasmid is repressed with 2% glucose 
and light gray histograms represent cells where expression of the plasmid gene is induced with 2% galactose. (C) Determina-
tion of the activation of the cell integrity pathway in myo1∆ strains overexpressing the ribosomal protein genes RPL30 and 
RPS31. Wild type, myo1∆, wildtype pRS316-RPL30, wild type pRS316-RPS31, myo1∆pRS316-RPL30 and myo1∆pRS316-RPS31 
strains were grown in CSM or CSM URA- in the presence of 2%glucose or 2% galactose. Equal amounts of protein (75 µg) were 
analyzed by Western blot as described in the Methods section. The phosphorylated levels of Slt2p were observed using a 
mouse monoclonal antibody against phospho-p42/p44 Slt2p (p-Slt2p). The membrane was stripped and reprobed with a mono-
clonal antibody against Pgk1p as a loading control.BMC Genomics 2008, 9:34 http://www.biomedcentral.com/1471-2164/9/34
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the p-Slt2p levels and conferred resistance to NZ in myo1∆
strains, suggesting that cell integrity was restored [24]. We
have now discovered that overexpression of RPL30 and
RPS31 can also up regulate the cell integrity pathway to
achieve a similar effect. It is unclear how such an altera-
tion in the level of transcription of individual RP genes
can affect this pathway but it is known that ribosome bio-
synthesis is a tightly regulated process in yeast that can be
affected by altering the stoichiometry of the individual
ribosomal subunits [25]. This observation could therefore
represent an effect of up regulation of ribosome biosyn-
thesis on cell integrity. Alternatively, the response of the
PKC1 pathway to changes in RP gene transcription may
represent one aspect of a novel feedback regulatory loop.
Others have reported that inhibition of the TOR pathway
by rapamycin treatment activated the PKC1 cell integrity
pathway in yeast cells [26]. It was acknowledged that inhi-
bition of the TOR pathway also results in repression of the
ribosomal biogenesis process [26]. The similarity of the
described phenotypes with those of myo1∆ strains merits
further investigation to determine if down regulation of
the TOR pathway is a contributing factor to the pheno-
types in these strains.
Methods
Strains and culture conditions
All the experiments were performed using Saccharomyces
cerevisiae wild type and myo1∆ strains listed in Table 3.
YJR6 is a myo1∆ ::HIS5 strain generated by homologous
recombination in the parental haploid wild type strain,
MGD-353-46D using a PCR based method. YJR12 (wild
type) and YJR13 (myo1∆) strains were obtained as haploid
segregants from a cross between YJR6 and BY4741
(obtained from ATCC). Cultures were grown overnight at
26°C to an optical density between 0.5–0.8 (OD600) in
complete synthetic media (CSM, 2% glucose, 1× Nitrogen
base) or Histidine dropout media (CSM-HIS-) with con-
tinuous shaking at 200 rpm. Where indicated in Table 3,
myo1∆ strains were transformed with plasmids containing
cDNAs for RPL30  (pRS316-RPL30) or RPS31  (pRS316-
RPS31) regulated by the GAL1  promoter, or MYO1
(pRS316-MYO1) regulated by its natural promoter.
RNA extraction procedure
Total RNA was extracted from 4 × 107 cells derived from
triplicate biological replicate cultures of strains MGD353-
46D, YJR6, YJR12, and YJR13 using the RNeasy Mini Kit
for isolation of total RNA (Qiagen, Hilden, Germany) fol-
lowing manufacturer's instructions. RNA concentrations
were determined by measuring absorbance at 260 nm
using a Nanodrop spectrophotometer (Nanodrop Tech-
nologies, Wilmington, DE). The purity and integrity of the
RNA was monitored using an Agilent Bioanalyzer (Agilent
Technologies, Palo Alto, CA) following manufacturer's
instructions.
DNA microarrays hybridization and analysis
1.0 µg of total RNA from each sample was amplified using
the Low RNA Input Fluorescent Linear Amplification kit
Table 2: Determination of the SLT2 gene mRNA fold change for 
wild type pRS316-RPL30, wild type pRS316-RPS31, myo1∆pRS316-
RPL30, and myo1∆pRS316-RPS31 strains grown under inducing 
(2% galactose) and repressing (2% glucose) conditions.
Strains SLT2 gene fold change
wild type pRS316-RPL30 1.21
wild type pRS316-RPS31 2.73
myo1∆ pRS316-RPL30 1.6
myo1∆ pRS316-RPS31 6.5
Table 3: Strains used in this study.
Strain Genotype Source
BY4741 MAT a his3delta1 leu2delta0 met15delta0 ura3delta0 ATCC
YJR12 (wild type) MAT α trp1 ura3 leu2-3 his3delta1 ADE+ ARG+ cyhR Lab. strain
YJR13 (myo1∆)M A T  a  trp1 ura3 leu2-3 his3delta1 ADE+ ARG cyhRmyo1delta::HIS5+ Lab. strain
MGD353-46D (wild type) MAT α trp1-289 ura3-52 leu2-3, 112 his3delta1 ADE+ ARG cyhR B. Rymond
YJR6 (myo1∆)M A T   α trp1-289 ura3-52 leu2-3, 112 his3delta1 ADE+ ARG cyhR myo1delta::HIS5+ 
parental MGD353-46D
F. Rivera
YJR13 pRS316-RPL30 (myo1∆ 
pRS316-RPL30)
MAT a trp1 ura3 leu2-3 his3delta1 ADE+ ARG cyhRmyo1delta::HIS5+, pRS316-RPL30 A. Brestcher (plasmid)
YJR13 pRS316-RPS31 (myo1∆ 
pRS316-RPS31)
MAT a trp1 ura3 leu2-3 his3delta1 ADE+ ARG cyhRmyo1delta::HIS5+, pRS316-RPS31 A. Brestcher (plasmid)
YJR13 pRS316-MYO1 (myo1∆ 
pRS316-MYO1)
MAT a trp1 ura3 leu2-3 his3delta1 ADE+ ARG cyhRmyo1delta::HIS5+, pRS316-MYO1 F. Rivera (plasmid)
YJR12 pRS316-RPL30 (wild type 
pRS316-RPL30)
MAT α trp1 ura3 leu2-3 his3delta1 ADE+ ARG+ cyhR pRS316-RPL30 A. Brestcher (plasmid)
YJR12 pRS316-RPS31 (wild type 
pRS316-RPS31)
MAT α trp1 ura3 leu2-3 his3delta1 ADE+ ARG+ cyhR pRS316-RPS31 A. Brestcher (plasmid)
YJF1 (myo1∆slt2∆ pRS316-MYO1)M A T  a  trp1 ura3 leu2-3 his3delta1 ADE+ ARG cyhRmyo1delta::HIS5+, pRS316-MYO1, 
slt2delta::KANR
This studyBMC Genomics 2008, 9:34 http://www.biomedcentral.com/1471-2164/9/34
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(Agilent Technologies, Palo Alto, CA). The amplified
cRNA was labeled with 10 mM Cyanine 5-CTP (Cy5) or
Cyanine 3-CTP (Cy3) (Perkin Elmer Life Sciences, Boston,
MA). Labeled cRNA's were purified with Qiagen RNeasy
mini spin columns and dye incorporation was monitored
on an Agilent Bioanalyzer. Hybridization of Cy5 and Cy3
labeled cRNA's were performed using Yeast Oligo Micro-
array slides and hybridization kit from Agilent Technolo-
gies in 1012AG hybridization chambers (Sheldon
Manufacturing, Cornelius, Oregon) at 60°C overnight.
Slides were washed at high stringency and scanned with a
VersArray Chip Reader system (BioRad, Hercules, CA) at a
resolution of 5 µm with detector sensitivity values
between 704–800 and laser power at 85%. Scanned
images were transferred to the Imagene 3.0 software pro-
gram (Biodiscovery, El Segundo, CA) for further analysis
to locate spots, adjust the appropriate grid, and obtain the
Cy3 and Cy5 TIFF files. The microarrays raw data gener-
ated with Imagene 3.0 were analyzed using Limma soft-
ware (Bioconductor Package 1.7). The data was prepared
for analysis by correcting for background intensity. The
individual data sets were normalized using the locally
weighted linear regression (Lowess) within each array.
After normalization, the difference between the experi-
mental and control signal was calculated, replicates were
combined, and their averages were calculated. The fold
change in gene expression was calculated by 2(M), where M
is the log2-fold change after background correction and
normalization. An Empirical Bayes Statistics for differen-
tial expression analysis [27] (eBayes statistics) was per-
formed by Limma. Genes with a p-value ≤ 0.01 were
established as a cutoff for differential expression. In addi-
tion, a false discovery rate (FDR) test [28] was performed
by Limma [14]. The microarray raw data and the proc-
essed data are available at Gene Expression Omnibus of
NCBI (GSE5931) [29].
Gene Set Enrichment Analysis
Gene Set Enrichment Analysis was performed using the
Limma package of Bioconductor [14]. For this purpose a
gene set file was created classifying all the genes included
in the microarray into groups according to their specific
involvement in a biological process. From this gene set, a
total of 25 categories were represented according to the
Osprey network visualization software [30], matching the
category with the t-value. Then, the Limma software calcu-
lated the average of the t-value for each category or biolog-
ical process. Significance of differential expression as
determined by the enrichment analysis was recalculated
10,000 times. A corrected p-value was obtained from the
analysis using the Bonferroni correction. The initial cutoff
to determine that the gene set was differentially expressed
was p-value ≤ 0.01. Based on this correction, the cutoff for
significance was established at a p-value ≤ 0.0004.
Confirmation of microarray data by real time RT-PCR
Real time RT-PCR assays were performed with 30 ng of
total RNA using the Quantitec SYBR Green RT-PCR kit
(Qiagen, Valencia, CA) with primers at 0.5 µM (Table 4)
and a final reaction volume of 25.0 µL, following manu-
facturer recommendations. The reactions were performed
following the conditions recommended by the manufac-
turer using the iCycler iQ Multicolor real time PCR detec-
tion system (BioRad, Hercules, CA). The PCR
quantification and melting curves were generated using
the iCycler new version software (BioRad, Hercules, CA).
The sequences of the forward and reverse primers for the
selected mRNAs are listed in Table 4. The fold change was
determined by the 2∆∆Ct method [31]. The ∆Ct of the con-
trol and experimental samples was calculated from the
threshold cycle of the target gene minus the threshold
cycle of the reference gene (ACT1). The ∆∆Ct was calcu-
lated by subtracting the ∆Ct of the control sample minus
∆Ct of the experimental sample.
Nikkomycin Z sensitivity assay in myo1∆ strains 
overexpressing ribosomal protein genes
The screening for Nikkomycin Z sensitivity suppression in
myo1∆ was performed as described in [24]. Briefly, 1 × 105
cells/ml of WT, myo1∆, myo1∆p RPL30 and myo1∆p RPS31
cells were grown in ura-glu- or ura-gal- in the presence or
absence of 6.25 µM Nikkomycin Z at 26°C and 225 rpm.
The OD600 nm was determined after 48 hrs of growth. The
Table 4: Primers used for real time RT-PCR in this study.
Target Forward primer Reverse primer
ACT1 5'-GCCATTTTGAGAATCGATTTG-3' 5'-TTAGAAACACTTGTGGTGAAC-3'
ECM4 5'-GTGGTACAAACGGAGCTTTCA-3' 5'-GTGCCCAATGGACTACGCTACA-3'
SPI1 5'-CCAGAACCAACGACTTTCGTA-3' 5'-ACTGCACCAGCCAAACCTA-3'
ROM1 5'-AGCTATCTACGCCTCCAACT-3' 5'-ATGATGACGTTGGTGTTGA-3'
SLT2 5'-AGCAACAGCAGCCTTCAGA-3' 5'-GAACGCGAGGAAGTATCCAA-3'
YHR097C 5'-CCATCGTCGTACATCACAC-3' 5'-GTACAGGCGCCACTTTATTA-3'
IRA2 5'-ACTCACCTTTCCGCTGAC-3' 5'- CATGACACATCGCTTCTACA-3'
RPL30 5'-GATCATCATTGCCGCTAACA-3' 5'-GAGACAACACCGACTCTGAATAACT-3
RPS31 5'-ACAAGGAAGGTATTCCACCTGA-3' 5'-TCTTTCTCTTCTTACCACCACCTC-3'BMC Genomics 2008, 9:34 http://www.biomedcentral.com/1471-2164/9/34
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% Nikkomycin Z resistance represents: (OD600 nm treated/
OD600 nm untreated) × 100.
SLT2 gene disruption in myo1∆ a background
The SLT2  gene disruption in the YJR13 pRS316-MYO1
strain was performed by replacing the SLT2 gene with a
KanMX4 module by homologous recombination using a
PCR based method [32]. The myo1∆ slt2∆ pRS316-MYO1
strain was grown in CSM 1 mg/ml 5-Fluoroorotic acid
(CSM 5-FOA) to extract the plasmid and obtain a
myo1∆slt2∆ double mutant.
Western blot analysis of phosphorylated Slt2p levels
Wild type, myo1∆, wild type pRS316-RPL30, wild type
pRS316-RPS31,  myo1∆  pRS316-RPL30, and myo1∆
pRS316-RPS31  yeast strains were grown in selective
medium in 2% glucose or 2% galactose to an OD600 0.5–
0.8 at 26°C, overnight. Cells were centrifuged for 5 min-
utes, washed in ice cold medium, and resuspended in lysis
buffer as described in [24]. Protein extract were centri-
fuged at 13,000 for 10 minutes at 4°C, the supernatant
was removed and quantified using the DC Protein Assay
method (BioRad). Total protein extracts (75 µg) were sep-
arated in a 10% SDS-PAGE gel and transferred to a nitro-
cellulose membrane at 30 V for 16 h at 4°C. Membrane
was incubated with anti-phospho-p42/44 MAP kinase
monoclonal antibody (1:2000) (Cell Signaling Technol-
ogy) to detect phosphorylated Slt2p levels. Membrane
was stripped and reprobed with a mouse monoclonal
antibody against Pgk1p (1:125 dilution) (Molecular
Probes, Invitrogen) as loading control.
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